ARCHIVES

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

DCPC Board Backs Diet Fit Trial

October 20, 1989

Herberman Outlines NSABP restructuring In Plan To NCI

May 6, 1994

CCRU, CCSP Projects Described; Plans Listed for DRCCA Applications Branch

November 11, 1983

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

September 20, 2013

In Brief: Administration Ignores Congressional Mandate To Revive Training Grants, Funds Fellowships

February 8, 1974

In Brief: Barry Pierce New DCCP Chairman; Adamson Seeks Ads For Chemical, Biological Carcinogenesis

June 17, 1983